Next Article in Journal
The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer
Next Article in Special Issue
Clinical Characterisation and Management of the Main Treatment-Induced Toxicities in Patients with Hepatocellular Carcinoma and Cirrhosis
Previous Article in Journal
Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study” Cancers 2020, 12, 3228
Previous Article in Special Issue
Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 30 December 2020 17:42 CET Original file -
article xml uploaded. 30 December 2020 17:42 CET Update -
article pdf uploaded. 30 December 2020 17:42 CET Version of Record https://www.mdpi.com/2072-6694/13/1/88/pdf-vor
article supplementary file uploaded. 30 December 2020 17:42 CET - https://www.mdpi.com/2072-6694/13/1/88#supplementary
article html file updated 30 December 2020 17:43 CET Original file -
article xml file uploaded 4 January 2021 09:55 CET Update -
article xml uploaded. 4 January 2021 09:55 CET Update https://www.mdpi.com/2072-6694/13/1/88/xml
article pdf uploaded. 4 January 2021 09:55 CET Updated version of record https://www.mdpi.com/2072-6694/13/1/88/pdf
article html file updated 4 January 2021 09:56 CET Update -
article html file updated 23 July 2022 08:51 CEST Update https://www.mdpi.com/2072-6694/13/1/88/html
Back to TopTop